TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/06/2026
Voltar para busca
Dado oficial do USPTO
HUMAN PHOTOSYNTHESIS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
HUMAN PHOTOSYNTHESIS
ST13
US500000077748311Classe
5
Pedido
77748311
Registro
4478337
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
95
Atualização mais recente
10/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
30/05/2009
Data de registro
04/02/2014
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/10/2023
Última transação
10/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Primeiro uso
11/06/2005
Primeiro uso no comércio
25/01/2013
Código do desenho
4
Tipo de titular
03
Localização do titular
Aguascalientes, MX
Examinador
CHANG, KATHERINE S
Unidade examinadora
M60
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
Formulas Magistrales SA de CV
Representantes
Holly M. Ford Lewis Panitch Schwarze Belisario & Nadel LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Homeopathic pharmaceuticals for smoking cessation; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with nicotine for smoking cessation; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system; for the treatment of inflammatory disorders; for use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesanti- infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; Pharmaceutical preparations for the prevention of arthritisAlzheimer's diseaseParkinson's disease; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparationsantidepressants; Pharmaceutical preparationsa drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticalsinducers of erections; Pharmaceuticalspsychotropics; Plant extracts for medicalveterinary and pharmaceutical purposes; Therapeutic pharmaceutical for smoking cessation
Publicações
Histórico de despachos e eventos da marca no USPTO.
95 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/06/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/06/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/06/2026
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
29/12/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
29/12/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
29/12/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29/12/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
29/12/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
29/12/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/11/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/11/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/11/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/11/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/11/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/11/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/04/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/04/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/04/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/04/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/04/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/04/2025
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
21/10/2023
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
21/10/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
21/10/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
21/10/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
25/04/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/02/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
21/02/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
21/02/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
21/02/2020
E815
TEAS SECTION 8 & 15 RECEIVED
20/12/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/02/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/02/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/02/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
04/02/2014
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/01/2014
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/01/2014
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/01/2014
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
31/12/2013
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
20/12/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/12/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/12/2013
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
19/12/2013
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/07/2013
GNFR
FINAL REFUSAL E-MAILED
09/07/2013
CNFR
SU - FINAL REFUSAL - WRITTEN
09/07/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/07/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/07/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/07/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/07/2013
GNRT
NON-FINAL ACTION E-MAILED
02/07/2013
CNRT
SU - NON-FINAL ACTION - WRITTEN
02/07/2013
SUPC
STATEMENT OF USE PROCESSING COMPLETE
26/06/2013
EISU
TEAS STATEMENT OF USE RECEIVED
24/06/2013
IUAF
USE AMENDMENT FILED
22/06/2013
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/01/2013
EX5G
SOU EXTENSION 5 GRANTED
09/01/2013
PAPER RECEIVED
31/12/2012
EXT5
SOU EXTENSION 5 FILED
22/12/2012
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21/06/2012
EX4G
SOU EXTENSION 4 GRANTED
20/06/2012
EXT4
SOU EXTENSION 4 FILED
19/06/2012
EEXT
SOU TEAS EXTENSION RECEIVED
19/06/2012
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/04/2012
UNDN
UNDELIVERABLE MAIL - NO ACTION TAKEN
01/02/2012
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
04/01/2012
EX3G
SOU EXTENSION 3 GRANTED
03/01/2012
EXT3
SOU EXTENSION 3 FILED
22/12/2011
EEXT
SOU TEAS EXTENSION RECEIVED
22/12/2011
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
25/06/2011
EX2G
SOU EXTENSION 2 GRANTED
24/06/2011
EXT2
SOU EXTENSION 2 FILED
22/06/2011
EEXT
SOU TEAS EXTENSION RECEIVED
22/06/2011
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
22/01/2011
EX1G
SOU EXTENSION 1 GRANTED
21/01/2011
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
21/01/2011
EXT1
SOU EXTENSION 1 FILED
22/12/2010
EEXT
SOU TEAS EXTENSION RECEIVED
22/12/2010
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
22/06/2010
PUBO
PUBLISHED FOR OPPOSITION
27/04/2010
NPUB
NOTICE OF PUBLICATION
07/04/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
22/03/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/03/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/03/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/03/2010
ALIE
ASSIGNED TO LIE
16/03/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/03/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/09/2009
GNRT
NON-FINAL ACTION E-MAILED
03/09/2009
CNRT
NON-FINAL ACTION WRITTEN
03/09/2009
DOCK
ASSIGNED TO EXAMINER
31/08/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/06/2009
NWAP
NEW APPLICATION ENTERED
03/06/2009
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HUMAN PHOTOSYNTHESIS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.